Opportunity Cost

This phenomenon goes by the name of ‘opportunity cost,’ since by not investing in more equipment and a more rigid production flow, the company is forgoing the opportunity to earn increased profits. These costs are every bite as real as the payment of dollars out-of-pocket.

This notion _______ opportunity cost can be reinforced _________ a famous saying ______ Benjamin Franklin, no slouch himself _________ operations management. To make the point, however, we must make a brief excursion into logic. One truth of logic is the validity of the so-called contrapositive, which says simply that if the statement “If A, then B” is true, then it is also true that “If not B, then not A.” That is, of every time A occurs B follows, then we can be sure that if B does not occur, then A did not occur as well. Enough logic then, and back to Ben Franklin.

One of his Poor Richard sayings is that “A penny saved is a penny earned.” We have all recognized the truth of that since childhood, but I assert that by this saying Ben showed us he knows everything about opportunity cost. After all, what is the contrapositive of “A penny not earned is a penny not saved (i.e., a penny sent). All we are saying by this notion of opportunity cost is that “a penny not earned (an opportunity forgone) is a penny spent.” We shall often have occasion to consider opportunity costs, in analyzing and deciding various operations issues.

SCHMENNER, Roger W. Production/Operations Management. 5th Edition. Prentice-Hall, 1993.

Text

A French art expert believes a charcoal drawing kept in a collection for more than 150 years may be a preparatory sketch made by Leonardo da Vinci of the Mona Lisa.

The black-and-white drawing of a woman, nude from the waist up, known as the Monna Vanna, was previously attributed to Leonardo’s studio, suggesting it was done in his style by a pupil or follower, not by the master himself.

But after preliminary tests at the Louvre Museum, experts believe the sketch may well have been drawn by Leonardo.

Among the signs, according to curator Mathieu Deldicque, are the fact the drawing was made during the same period as the Mona Lisa, the paper is from the same region of Italy, and the technique is very similar to that of the Mona Lisa.

“We know the drawing was made during the lifetime of Leonardo da Vinci, we know that the paper was made in Italy, between Venice and Florence, and the third discovery is the high quality of this drawing in the face of the Monna Vanna and in her arms,” Deldicque told reporters.

“That’s very interesting because the arms are the same as the Mona Lisa‘s.”

Leonardo, who lived from 1452 to 1519, was an engineer, scientist, inventor and sculptor, as well as one of the finest artists of the Italian Renaissance.

He painted the Mona Lisa, also known as La Gioconda and regarded as the world’s most valuable artwork, at the beginning of the 16th century. It is believed to depict Lisa Gherardini, the wife of a successful merchant.

EXCITING

The charcoal portrait, in which the woman is holding a similar pose to the Mona Lisa but with her body more side-on and her head turned further over her left shoulder, has been held in a collection at the Conde Museum at the Palace of Chantilly, north of Paris, since 1862.

The Mona Lisa and Monna Vanna hold their hands in very similar ways, the right hand across the left and resting on the forearm, the fingers gently extended.

Deldicque said that while it was exciting to think the charcoal drawing was created by Leonardo, there were more tests to be done.

“We have one more month of analysis and then a very slow process of history of art with a collection of analysts and advice by specialists,” he said. 

It is possible that process will determine that the authorship is the same. But it may also be inconclusive, he said, adding:

“Maybe the mystery will remain.”

(Source: adapted from http://www.reuters.com/article/us-france-monalisa-sketch/is-16th-century-charcoal-sketch-a-naked-mona-lisa-idUSKCN1C42LD, retrieved on October 1, 2017) 

The true potential of technology to change behavior

    Technology could successfully change behaviours where decades of campaigns and legislation have failed. With the quantified self already walking among us and the internet of things within easy reach, digital technology is creating unprecedented opportunities to encourage, enable and empower more sustainable behaviours.

     If we are to unlock the power of technology we must be more ambitious than simply digitising analogue strategies or creating another communications channel.

    The true potential of technology lies in its ability to do things that nothing else can do. In behaviour change terms, the potential to succeed where decades of education programmes, awareness campaigns and product innovation have failed; to make a difference where government policy and legislation has had limited impact.

    Using behavioural insights, it is possible to highlight the bottlenecks, drop out points and achilles heels of traditional behaviour change efforts — the reasons why we have failed in the past — and apply the unique possibilities of technology to these specific challenges.

    Overcoming our limitations

    Luckily, the history of the human race is almost defined by its ability to invent stuff that bolsters its feeble capabilities. That stuff is, of course, what we generically refer to as 'technology'. And in the same way that the internal combustion engine and the light bulb allow us to overcome our relatively feeble powers of motion and perception, so digital technology can be directed to overcoming our relatively feeble powers of reasoning, selfcontrol, motivation, self-awareness and agency—the factors that make behaviour change so difficult.

    Herein lies the true potential of technology: not in the laboratory or the workshop, but in an understanding of the behavioural dynamics that define the human condition, both generally and within the context of a specific user-group, market segment or community.

Fonte: JOHNSON, Steven. Recognising the true potential of technology to change behaviour. Disponível em:<https://www.theguardian.com/sustainablebusiness/behavioural-insights/true-potential-technology-change-behaviour> . Acesso em: 23 ago. 2017. (Adaptado). 

Read TEXT 1 below and answer question

TEXT 1

World Health Officials Describe Progress Against Tetanus, H.I.V. and Malaria

    Infant and maternal tetanus was officially eliminated from the Americas this year, the Pan American Health Organization announced on Thursday. At one time, the infection killed about 10,000 newborns annually in the Western Hemisphere; tetanus still kills about 35,000 infants around the world. It was one of several significant global health advances, including new programs against malaria and H.I.V., announced last week in conjunction with the meeting of the United Nations General Assembly in New York.
    Haiti was the last country in the Americas to eliminate neonatal tetanus. That does not mean complete eradication, because the bacteria that cause tetanus exist everywhere in soil and animal droppings. Rather, elimination means that thanks to vaccination of mothers and clean birth procedures — less than one case occurs per 1,000 live births.
    The Americas have generally led the world in eliminating diseases for which vaccines exist. In this hemisphere, smallpox was eliminated in 1971, polio in 1994, rubella in 2015 and measles in 2016 (the diseases are sometimes reintroduced, as measles was at Disneyland in 2014, but outbreaks are usually brought quickly under control).
    Also this week, the President’s Malaria Initiative said it would expand its work to new countries in West and Central Africa, protecting 90 million more people. The initiative, founded in 2005 as part of the United States Agency for International Development, has been a major force in driving down worldwide malaria deaths by about 40 percent in the past decade. The disease most often kills young children and pregnant women. The expansion in Cameroon, Ivory Coast, Niger, Sierra Leone and Burkina Faso was made possible because Congress increased funding for the initiative in fiscal year 2017, a representativ said
    In his speech to the United Nations on Tuesday, President Trump praised the malaria initiative and the President’s Emergency Plan for AIDS Relief as examples of leadership in humanitarian assistance by the United States.
    A combination of aid agencies, drug companies and g cocktail to treat H.I.V. would soon be available to 92 countries, including virtually all of Africa, for about $75 a year. The new AIDS cocktail is the first available in poor countries to contain dolutegravir, which is widely used in wealthy countries because it is highly effective and has few side effects. The pill also contains lamivudine, an older but still effective drug, and tenof disoproxil fumarate, another modern drug whose inclus effects and resistance.
    Almost 37 million people in the world have H.I.V., according to Unaids, the U.N.’s AIDS-fighting agency, but fewer than 20 million are now on antiretroviral medicine, which not only saves their lives but prevents them from passing on the disease.

McNEIL Jr., Donald. Disponível em: < https://www.nytimes.com/2017/09/22/health/world-health-tetanus-infants.html?mcubz=1>. Acesso em: 22/09/2017. 

Text1

Autism's Drug Problem 

Many people on the spectrum take multiple medications, which can lead to serious side effects and may not even be effective

Connor was diagnosed with autism early — when he was just 18 months old. His condition was already obvious by then. “He was lining things up, switching lights on and off, on and off,” says his mother, Melissa. He was bright, but he didn’t speak much until age 3, and he was easily frustrated. Once he started school, he couldn’t sit still in class, called out answers without raising his hand and got visibly upset when he couldn’t master a math concept or a handwriting task quickly enough. “One time, he rolled himself up into the carpet like a burrito and wouldn’t come out until I got there,” Melissa recalls. (All families in this story are identified by first name only, to protect their privacy.) 
Connor was prescribed his first psychiatric drug, methylphenidate (Ritalin), at age 6. That didn’t last long, but when he was 7, his parents tried again. A psychiatrist suggested a low dose of amphetamine and dextroamphetamine (Adderall), a stimulant commonly used to treat attention deficit hyperactivity disorder (ADHD). The drug seemed to improve his time at school: He was able to sit still for longer periods of time and focus on what his teachers were saying. His chicken-scratch handwriting became legible. Then, it became neat. Then perfect. And then it became something Connor began to obsess over.
“We were told that these are the gives and takes; if it’s helping him enough to get through school, you have to decide if it’s worth it,” Melissa says. It was worth it — for a while.  
But when the Adderall wore off each day, Connor had a tougher time than ever. He spent afternoons crying and refusing to do much of anything. The stimulant made it difficult for him to fall asleep at night. So after a month or two, his psychiatrist added a second medication — guanfacine (Intuniv), which is commonly prescribed for ADHD, anxiety and hypertension, but can also help with insomnia. The psychiatrist hoped it might both ease Connor’s afternoons and help him sleep. 
In some ways, it had the opposite effect. His afternoons did get slightly better, but Connor developed intense mood swings and was so irritable that every evening was a struggle. Rather than simply tossing and turning in bed, he refused to even get under the covers. “He wouldn’t go to bed because he was always angry about something,” Melissa says. “He was getting himself all wound up, carrying on, getting upset at night and crying.” 
 wound up, carrying on, getting upset at night and crying.” After seven months, his parents declared the combination unsustainable. They swapped guanfacine for over-the-counter melatonin, which helped Connor fall asleep with no noticeable side effects. But within a year, he had acquired a tolerance for Adderall. Connor’s psychiatrist increased his dosage and that, in turn, triggered tics: Connor began jerking his head and snorting. Finally, at his 9-year physical, his doctor discovered that he’d only grown a few inches since age 7. He also hadn’t gained any weight in two years; he’d dropped from the 50th percentile in weight to the 5th. That was the end of all the experiments. His parents took him off all prescription drugs, and today, at almost 13 years old, Connor is still medication-free. His tics have mostly disappeared. Although he has trouble maintaining focus in class, his mother says that the risk-benefit ratio of trying another drug doesn’t seem worth it. “Right now we’re able to handle life without it, so we do.”
(...)
For Connor, eliminating prescription drugs was difficult, but doable. For others, multiple medications may seem indispensable. It’s not unusual for children with autism to take two, three, even four medications at once. Many adults with the condition do so, too. Data are scant in both populations, but what little information there is suggests multiple prescriptions are even more common among adults with autism than in children. Clinicians are particularly concerned about children with the condition because psychiatric medications can have long-lasting effects on their developing brains, and yet are rarely tested in children. 
In general, polypharmacy — most often defined as taking more than one prescription medication at once — is commonplace in people with autism. In one study of more than 33,000 people under age 21 with the condition, at least 35 percent had taken two psychotropic medications simultaneously; 15 percent had taken three.
“Psychotropic medications are used pretty extensively in people with autism because there aren’t a lot of treatments available,” says Lisa Croen, director of the Autism Research Program at Kaiser Permanente in Oakland, California. “Is heavy drug use bad? That’s the question. We don’t know; it hasn’t been studied.”

  Disponível em: <https://www.scientificamerican.com/article/autisms-drug-problem/>. Texto adaptado. 

         Drinking coffee could help you live longer Coffee not only helps you feel full of beans, it might add years to your life as well, two major studies have shown. Scientists in Europe and the US have uncovered the clearest evidence yet that drinking coffee reduces the risk of death.

         One study of more than half a million people from 10 European countries found that men who downed at least three cups of coffee a day were 18% less likely to die from any cause than non-coffee drinkers. Women drinking the same amount benefited less, but still experienced an 8% reduction in mortality over the period measured.

        Similar results were reported by American scientists who conducted a separate investigation, recruiting 185855 participants from different ethnic backgrounds. Irrespective of ethnicity, people who drank two to three cups of coffee daily had an 18% reduced risk of death.

        Each of the studies, both published in the journal Annals of Internal Medicine, showed no advantage from drinking either caffeinated or decaffeinated coffee. Experts believe the antioxidant plant compounds in coffee rather than caffeine are responsible for the life-extending effect. Previous research has suggested that drinking coffee can reduce the risk of heart disease, diabetes, liver disease, and some cancers.

         Dr Marc Gunter, from the International Agency for Research on Cancer, who led the European study with colleagues from Imperial College London, said: “We found that higher coffee consumption was associated with a lower risk of death from any cause and specifically for circulatory diseases and digestive diseases. Importantly, these results were similar across all of the 10 European countries, with variable coffee drinking habits and customs. Our study also offers important insights into the possible mechanisms for the beneficial health effects of coffee.”

(www.huffingtonpost.co.uk, 11.07.2017. Adaptado.)

Read the text below and answer the following questions based on it.

The Healing Power of Music

What better “medicine” than a “treatment” that has only positive side effects and “therapy” that is actually enjoyable? Music is shown to have the ability to help organize the brain; especially vital to those who are afflicted with Alzheimer’s.

Studies have shown that the results of a musical therapy session last for several hours afterward. Positive results include elevated mood, increased socialization and appetite and reduction in agitation. These benefits are attributed to the stimulation the brain receives during a music therapy session, a sort of “cognitive workout”.

As speech, writing and traditional forms of communication are compromised, music provides an alternative means of maintaining a connection, thereby helping to normalize interaction between caregiver and patient. Music used therapeutically creates an environment where the patient can be nurtured and cared for in a way that is safe, gentle and appropriate. Music is central to maintaining human bonds when those with dementia have lost the ability to initiate communication or to respond verbally.

The powers of music when focused and used therapeutically are many. Critical to maintaining quality of life for those with Alzheimer’s is management of emotions and preserving the connection with others. Music is conducive to keeping those connections strong as long as possible while helping the participant to focus, increase awareness and orient to the environment. A number of research studies have looked at music therapy as an important adjunct to medical treatment and findings suggest a possible link between the use of music and slowing the progression of dementia.

Music is primal to life and expressed by each of us every day whether through dancing to a favorite tune, keeping rhythm with a pencil or remembering a special time when hearing a forgotten melody. It is central to our lives and is embedded in our culture, defining how we acknowledge milestones, rites of passage and celebrations as well as providing comfort, transformation and inspiration.

         Acessado em 14 de abril de 2017. Adaptado

Read the text below and answer the following questions based on it.

In 2017 the protestant church is celebrating an important event: the 500th anniversary of the Reformation

Examine a tira para responder à questão.

Question: Is there anything I can do to train my body to need less sleep?

Karen Weintraub

June 17, 2016

   Many people think they can teach themselves to need less sleep, but they’re wrong, said Dr. Sigrid Veasey, a professor at the Center for Sleep and Circadian Neurobiology at the University of Pennsylvania’s Perelman School of Medicine. We might feel that we’re getting by fine on less sleep, but we’re deluding ourselves, Dr. Veasey said, largely because lack of sleep skews our self-awareness. “The more you deprive yourself of sleep over long periods of time, the less accurate you are of judging your own sleep perception,” she said.

   Multiple studies have shown that people don’t functionally adapt to less sleep than their bodies need. There is a range of normal sleep times, with most healthy adults naturally needing seven to nine hours of sleep per night, according to the National Sleep Foundation. Those over 65 need about seven to eight hours, on average, while teenagers need eight to 10 hours, and school-age children nine to 11 hours. People’s performance continues to be poor while they are sleep deprived, Dr. Veasey said.

   Health issues like pain, sleep apnea or autoimmune disease can increase people’s need for sleep, said Andrea Meredith, a neuroscientist at the University of Maryland School of Medicine. A misalignment of the clock that governs our sleep-wake cycle can also drive up the need for sleep, Dr. Meredith said. The brain’s clock can get misaligned by being stimulated at the wrong time of day, she said, such as from caffeine in the afternoon or evening, digital screen use too close to bedtime, or even exercise at a time of day when the body wants to be winding down.

(http://well.blogs.nytimes.com. Adaptado.)

A new planet in our neighborhood - how likely is life there?

By Don Lincoln, August 24, 2016

Scientists working at the European Southern Observatory (ESO), using the La Silla telescope, claim to have discovered the closest exoplanet to Earth. Exoplanet means planets orbiting stars other than the Sun. Most of them are huge planets orbiting very near their star. The newly discovered planet, which orbits Proxima Centauri, a star within the so-called “habitable zone”, has been named Proxima b.

Proxima Centauri is a red dwarf, which is the most common type of star in the galaxy. Red dwarfs are much smaller than our Sun, and are very dim. For instance, in the visible spectrum that we use to see, Proxima Centauri gives off 0.0056% as much light as the Sun.

So what about life? Are there any chances that an alien lizard might bask in Proxima Centauri’s light or try to find shade under an alien tree? Dr. Guillem Anglada-Escudé, co-author of the research from London University, believes that “there is a reasonable expectation that this planet might be able to host life”

But this belief is not consensual as other scientists think the prospect of life is improbable. Although the temperature of the planet is thought to be such that liquid water could exist, it is unlikely that Proxima b is habitable, as the planet is subject to stellar wind pressures of more than 2000 times those experienced by Earth from the solar wind. These winds would likely blow any atmosphere away, leaving the undersurface as the only vaguely habitable location on that planet. You shouldn’t imagine, thus, a lush and verdant world, with lovely blue waters, sandy beaches and green plants.

So, what’s the bottom line? First, the discovery is extremely exciting. The existence of a nearby planet in the habitable zone will perhaps increase the interest in efforts like Project Starshot, which aims to send microprobes (instruments that apply a stable and wellfocused beam of charged particles -electrons or ions- to a sample) to Proxima Centauri. On the other hand, Proxima b is unlikely to be a haven for people trying to escape the ecological issues of Earth, so we should not view this discovery as a way to ignore our own ecosystem.

Adapted from: < http://edition.cnn.com/2016/08/24/opinions/nearbyplanet-opinion-lincoln/> Access Oct. 2016.

Glossário:

claim: afirmar; dwarf: anão; dim: opaco; give off: emitir; lizard: lagarto; bask: aquecer-se; belief: crença; wind: vento; undersurface: camada inferior; lush: viçoso; bottom line: aspecto fundamental; aim: visar/ter por objetivo; sample: amostra; haven: refúgio.

Leia o texto para responder à questão.

Disparity in life spans of the rich and the poor is growing

Sabrina Tavernise

February 12, 2016

      Experts have long known that rich people generally live longer than poor people. But a growing body of data shows a more disturbing pattern: Despite big advances in medicine, technology and education, the longevity gap between high-income and low-income Americans has been widening sharply.

      The poor are losing ground not only in income, but also in years of life, the most basic measure of well-being. In the early 1970s, a 60-year-old man in the top half of the earnings ladder could expect to live 1.2 years longer than a man of the same age in the bottom half, according to an analysis by the Social Security Administration. Fast-forward to 2001, and he could expect to live 5.8 years longer than his poorer counterpart.

      New research released this month contains even more jarring numbers. Looking at the extreme ends of the income spectrum, economists at the Brookings Institution found that for men born in 1920, there was a six-year difference in life expectancy between the top 10 percent of earners and the bottom 10 percent. For men born in 1950, that difference had more than doubled, to 14 years. For women, the gap grew to 13 years, from 4.7 years. “There has been this huge spreading out,” said Gary Burtless, one of the authors of the study.

      The growing chasm is alarming policy makers, and has surfaced in the presidential campaign. During a Democratic debate, Senator Bernie Sanders and Hillary Clinton expressed concern over shortening life spans for some Americans. “This may be the next frontier of the inequality discussion,” said Peter Orszag, a former Obama administration official now at Citigroup, who was among the first to highlight the pattern. The causes are still being investigated, but public health researchers say that deep declines in smoking among the affluent and educated may partly explain the difference.

      Overall, according to the Brookings study, life expectancy for the bottom 10 percent of wage earners improved by just 3 percent for men born in 1950 compared with those born in 1920. For the top 10 percent, though, it jumped by about 28 percent. (The researchers used a common measure – life expectancy at age 50 – and included data from 1984 to 2012.)

                                                                            (www.nytimes.com. Adaptado.)